Bioventus (NASDAQ: BVS) director Sutter awarded 25,146 RSUs and exercises 32,282 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bioventus director and 10% owner Martin P. Sutter reported equity compensation and related share movements. On June 3, 2026, he received a grant of 25,146 Restricted Stock Units (RSUs), each representing a contingent right to one share of Class A common stock, scheduled to vest based on future board service conditions. On June 2, 2026, 32,282 RSUs vested and were exercised, delivering the same number of Class A shares and bringing his direct Class A holdings to 117,523 shares. The filing also shows 13,021,324 Class A shares held indirectly through EW Healthcare Partners Acquisition Fund, L.P. and White Pine Medical, LLC, where Sutter is one of several managers; these managers disclaim beneficial ownership except to the extent of their pecuniary interests.
Positive
- None.
Negative
- None.
Insider Trade Summary
32,282 shares exercised/converted
Mixed
4 txns
Insider
SUTTER MARTIN P
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,146 | $0.00 | -- |
| Exercise | Restricted Stock Units | 32,282 | $0.00 | -- |
| Exercise | Class A Common Stock | 32,282 | $0.00 | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 25,146 shares (Direct, null);
Class A Common Stock — 117,523 shares (Direct, null);
Class A Common Stock — 13,021,324 shares (Indirect, See Footnote)
Footnotes (1)
- Includes 12,096,702 shares of Class A Common Stock held by EW Healthcare Partners Acquisition Fund, L.P. ("Essex Stockholder") and 924,622 shares of Class A Common Stock held by White Pine Medical, LLC ("White Pine"). EW Healthcare Partners Acquisition Fund UGP, LLC ("General Partner") is the general partner of EW Healthcare Partners Acquisition Fund GP, L.P., which is the general partner of Essex Stockholder, which is the managing member of White Pine. Messrs. Sutter, Vainio, Eastman, and Barry (collectively, the "Managers") are the managers of the General Partner. The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs vested on June 2, 2026. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Key Figures
New RSU grant: 25,146 RSUs
RSUs vested and exercised: 32,282 RSUs
Direct Class A holdings: 117,523 shares
+3 more
6 metrics
New RSU grant
25,146 RSUs
Grant on June 3, 2026 to Martin P. Sutter
RSUs vested and exercised
32,282 RSUs
Vested and converted to Class A on June 2, 2026
Direct Class A holdings
117,523 shares
Class A common stock held directly after transactions
Indirect Class A holdings total
13,021,324 shares
Indirect Class A shares via Essex Stockholder and White Pine
Essex Stockholder position
12,096,702 shares
Class A common stock held by EW Healthcare Partners Acquisition Fund, L.P.
White Pine position
924,622 shares
Class A common stock held by White Pine Medical, LLC
Key Terms
Restricted Stock Units, Class A Common Stock, beneficial ownership, pecuniary interest
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
beneficial ownership financial
"The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein."
FAQ
What did Bioventus (BVS) director Martin P. Sutter report in this Form 4?
Martin P. Sutter reported equity compensation activity, including a new RSU grant and the vesting of existing RSUs into Class A common stock, along with updated direct and indirect share holdings tied to investment entities associated with him and other managers.
How many Restricted Stock Units did Martin P. Sutter receive from Bioventus (BVS)?
Sutter received a grant of 25,146 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Bioventus Class A common stock, subject to vesting conditions tied to continued service on the company’s Board of Directors.
What RSUs vested for Martin P. Sutter in the latest Bioventus (BVS) filing?
On June 2, 2026, 32,282 RSUs vested for Sutter and were converted into the same number of Class A common shares. This increased his direct common stock holdings reported in the filing to 117,523 Class A shares after the transaction.
What are Martin P. Sutter’s direct Class A common stock holdings in Bioventus (BVS)?
Following the RSU vesting and conversion, Sutter’s direct ownership stands at 117,523 shares of Class A common stock. These shares are held in his own name, separate from additional indirect holdings reported through affiliated investment entities.
What indirect Bioventus (BVS) holdings are associated with Martin P. Sutter?
The filing lists 13,021,324 Class A shares held indirectly via EW Healthcare Partners Acquisition Fund, L.P. and White Pine Medical, LLC. Sutter is one of several managers of the general partner and the managers disclaim beneficial ownership except for their pecuniary interests.
How do the new RSUs for Martin P. Sutter in Bioventus (BVS) vest?
The RSUs granted to Sutter vest on the earlier of the day immediately preceding Bioventus’ first Annual Meeting of Stockholders after the grant date or the first grant anniversary, provided he continues serving on the Board through the applicable vesting date.